Observational analysis explores antitumor therapy risks in patients with cardiovascular diseases, suggesting tailored treatment approaches.
Modern oncology is faced with the problem of treating malignant neoplasms in patients with severe cardiovascular diseases, such as heart failure, coronary heart disease, hypertension, cardiomyopathy and rhythm disorders. Antitumor therapy (chemotherapy, targeted drugs, immunotherapy, radiation therapy) can exacerbate cardiovascular risks, which requires a special approach to the choice of treatment, minimizing risks and maintaining the effectiveness of antitumor therapy.
No takes yet. Share an insight, caveat, or question.
Zorina et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: